RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China SXT Pharmaceuticals Stock

China SXT Pharmaceuticals ROE 2024

China SXT Pharmaceuticals ROE

-0.22

Ticker

SXTC

ISIN

VGG2161P1163

In 2024, China SXT Pharmaceuticals's return on equity (ROE) was -0.22, a -36.37% increase from the -0.35 ROE in the previous year.

China SXT Pharmaceuticals Aktienanalyse

What does China SXT Pharmaceuticals do?

China SXT Pharmaceuticals Inc is a Chinese company specializing in the development, manufacturing, and marketing of traditional Chinese medicines (TCM). It was founded in 2005 and is headquartered in Taizhou City, Jiangsu Province. The company is publicly listed on the Nasdaq. The company was founded in 2005 by Dr. Feng Zhou and other experts in the field of TCM. It quickly grew and established itself successfully in the market, becoming one of the leading companies in the TCM industry in China. China SXT Pharmaceuticals Inc's business model is based on the development, manufacturing, and marketing of TCM products. The company has an extensive portfolio of products based on traditional Chinese remedies. It combines traditional and modern methods of medicine and constantly strives to improve the quality of its products. The company is divided into three business segments. The first segment focuses on the TCM industry, where the company develops and manufactures its products and operates a research and development department. The second segment is regular pharmacies, where brand awareness is increased and products are marketed through distribution efforts. The third segment is online sales, where customers can order products directly through various platforms. The company offers a wide range of products based on traditional Chinese remedies. The product range includes treatments for various diseases, including cancer and viral diseases. Many products in the range are patented and exclusively available from China SXT Pharmaceuticals Inc. One of the most well-known product lines is the "Shenqi" range, used for the treatment of kidney diseases and high blood pressure. In recent years, the company has focused on expanding internationally and aims to increase its presence in the global market. It has made several acquisitions and acquisitions both domestically and internationally to expand its portfolio and strengthen its presence in the global market. China SXT Pharmaceuticals Inc has over 200 registered products in China and operates in over 30 countries. It is one of the top 20 companies in the Chinese TCM industry and has built a solid reputation through its expertise in TCM over the years. In summary, China SXT Pharmaceuticals Inc is an innovative and emerging company in traditional medicine. It aims to strengthen its presence in the global market and take a leading role in the development and manufacturing of TCM products. With its wide product range, high quality, and focus on innovation and progress, it is one of the most promising companies in the TCM industry in China. China SXT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding China SXT Pharmaceuticals's Return on Equity (ROE)

China SXT Pharmaceuticals's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing China SXT Pharmaceuticals's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

China SXT Pharmaceuticals's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in China SXT Pharmaceuticals’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about China SXT Pharmaceuticals stock

What is the ROE (Return on Equity) of China SXT Pharmaceuticals this year?

The ROE of China SXT Pharmaceuticals this year is -0.22 undefined.

How has the Return on Equity (ROE) of China SXT Pharmaceuticals developed compared to the previous year?

The ROE of China SXT Pharmaceuticals has increased by -36.37% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of China SXT Pharmaceuticals?

A high ROE indicates that China SXT Pharmaceuticals generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of China SXT Pharmaceuticals?

A low ROE can indicate that China SXT Pharmaceuticals is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of China SXT Pharmaceuticals affect the company?

A change in ROE (Return on Equity) of China SXT Pharmaceuticals can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of China SXT Pharmaceuticals?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of China SXT Pharmaceuticals?

Some factors that can influence China SXT Pharmaceuticals's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does China SXT Pharmaceuticals pay?

Over the past 12 months, China SXT Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, China SXT Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of China SXT Pharmaceuticals?

The current dividend yield of China SXT Pharmaceuticals is .

When does China SXT Pharmaceuticals pay dividends?

China SXT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of China SXT Pharmaceuticals?

China SXT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of China SXT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is China SXT Pharmaceuticals located?

China SXT Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von China SXT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China SXT Pharmaceuticals from 10/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/19/2024.

When did China SXT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/19/2024.

What was the dividend of China SXT Pharmaceuticals in the year 2023?

In the year 2023, China SXT Pharmaceuticals distributed 0 USD as dividends.

In which currency does China SXT Pharmaceuticals pay out the dividend?

The dividends of China SXT Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China SXT Pharmaceuticals

Our stock analysis for China SXT Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China SXT Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.